Partial lower axillary dissection for patients with clinically node-negative breast cancer

Journal of International Medical Research

Volumn 40, Issue 6, 2012, Pages 2336-2345

  Kodama, H ^a   Mise, K ^a   Kan, N ^a  

^a Kodama Breast Clinic   (Japan)

Author keywords

Axillary lymph node dissection; Breast cancer; Complication rate; Nodenegative breast cancer; Partial axillary lymph node dissection; Survival rate

Indexed keywords

DOXIFLURIDINE; ESTROGEN RECEPTOR; FLUOROURACIL; PROGESTERONE RECEPTOR; TAMOXIFEN;

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LYMPH NODE DISSECTION; LYMPHATIC DRAINAGE; LYMPHEDEMA; MAJOR CLINICAL STUDY; MASTECTOMY; OBSERVATIONAL STUDY; OPERATION DURATION; OVERALL SURVIVAL; PARTIAL LOWER AXILLARY DISSECTION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; RETROSPECTIVE STUDY; SURGICAL TECHNIQUE; SURVIVAL RATE; TRIPLE NEGATIVE BREAST CANCER;

EID: 84872224854     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/030006051204000632     Document Type: Article

References (25)

1. NIH Consensus Conference. Treatment of earlystage breast cancer. JAMA 1991; 265: 391-395.
2. Lyman GH, Giuliano AE, Somerfield MR, et al: American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005; 23: 7703-7720.
3. Kuehn T, Bembenek A, Decker T, et al: A concept for the clinical implementation of sentinel lymph node biopsy in patients with breast carcinoma with special regard to quality assurance. Cancer 2005; 103: 451-461.
4. Singletary SE, Allred C, Ashley P, et al: Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 2002; 20: 3628-3636.
5. Fisher B, Montague E, Redmond C, et al: Comparison of radical mastectomy with alternative treatments for primary breast cancer. A first report of results from a prospective randomized clinical trial. Cancer 1977; 39(6 suppl): 2827-2839.
6. Fisher B, Redmond C, Fisher ER, et al: Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 1985; 312: 674-681.
7. Giuliano AE, Hunt KK, Ballman KV, et al: Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 2011; 305: 569-575.
8. Early Breast Cancer Trialists' Collaborative Group: Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. N Engl J Med 1995; 333: 1444-1455.
9. Knauer M, Gnant M, Fitzal F: Results of the first Austrian multidisciplinary expert panel on controversies in local treatment of breast cancer. Breast Care (Basel) 2012; 7: 61-66.
10. Zavagno G, De Salvo GL, Scalco G, et al: A randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial. Ann Surg 2008; 247: 207-213.
11. Bilimoria KY, Bentrem DJ, Hansen NM, et al: Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer. J Clin Oncol 2009; 27: 2946-2953.
12. Kodama H, Nio Y, Iguchi C, et al: Ten-year follow-up results of a randomised controlled study comparing level-I vs level-III axillary lymph node dissection for primary breast cancer. Br J Cancer 2006; 95: 811-816.
13. Ashikaga T, Krag DN, Land SR, et al: Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol 2010; 102: 111-118.
14. Gill G, The SNAC Trial Group of the Royal Australasian College of Surgeons (RACS) and NHMRC Clinical Trials Centre: Sentinel-lymphnode- based management or routine axillary clearance? One-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): a randomized controlled surgical trial. Ann Surg Oncol 2009; 16: 266-275.
15. Mansel RE, Fallowfield L, Kissin M, et al: Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial. J Natl Cancer Inst 2006; 98: 599-609.
16. Sobin LH, Wittekind C (eds): TNM Classification of Malignant Tumors Edition 6. New Jersey: John Wiley and Sons, 2002; pp 131-142.
17. Kodama H: Modification of muscle-preserving radical mastectomy. Cancer 1979; 44: 1517-1522.
18. Auchincloss H: Significance of location and number of axillary metastases in carcinoma of the breast: a justification for a conservative operation. Ann Surg 1963; 158: 37-46.
19. Pesek S, Ashikaga T, Krag LE, et al: The falsenegative rate of sentinel node biopsy in patients with breast cancer: a meta-analysis. World J Surg 2012; 36: 2239-2251.
20. Giuliano AE, McCall L, Beitsch P, et al: Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg 2010; 252: 426-433.
21. Imoto S, Wada N, Murakami K, et al: Prognosis of breast cancer patients treated with sentinel node biopsy in Japan. Jpn J Clin Oncol 2004; 34: 452-456.
22. van der Ploeg IM, Nieweg OE, van Rijk MC, et al: Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: a systematic review and meta-analysis of the literature. Eur J Surg Oncol 2008; 34: 1277-1284.
23. Rutgers EJ: Sentinel node biopsy: interpretation and management of patients with immunohistochemistry-positive sentinel nodes and those with micrometastases. J Clin Oncol 2008; 26: 698-702.
24. Steele RJ, Forrest AP, Gibson T, et al: The efficacy of lower axillary sampling in obtaining lymph node status in breast cancer: a controlled randomized trial. Br J Surg 1985; 72: 368-369.
25. Hadjiminas DJ, Burke M: Intraoperative assessment of nodal status in the selection of patients with breast cancer for axillary clearance. Br J Surg 1994; 81: 1615-1616.